Page results
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
File results
-
FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment
-
FOI/2023/0809 - Equality, Diversity and Inclusion staff spend/ improved patient outcomes
-
FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy
-
FOI/2023/0811 - HIFU partial ablation/ prostate cancer detection
-
FOI/2023/0813 - Ulcerative colitis/ crohn's disease
-
FOI/2023/0815 - Birth data; live births/ stillbirths/ neonatal deaths
-
FOI/2023/0817 - Bed sores, pressure sores and pressure ulcers statistics
-
FOI/2023/0822 - Bank staff pay rates
-
FOI/2023/0827 - Consultation on future of EDS services
-
FOI/2023/0829 - Immunoglobulin treatments